StockSelector.com
  Research, Select, & Monitor Thursday, February 27, 2020 8:56:05 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Ligand Pharmaceuticals, Inc.$109.80$7.187.00%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Ligand Pharmaceuticals, Inc. has an overall rank of 77 out of 6467 stocks based on 13 positive rankings and 7 negative rankings.

Positive Rankings
Highest Net Margin
Ligand Pharmaceuticals rank is 5
Highest ROA
Ligand Pharmaceuticals rank is 9
Highest ROE
Ligand Pharmaceuticals rank is 30
Highest Cash Growth
Ligand Pharmaceuticals rank is 60
Estimated EPS Growth
Ligand Pharmaceuticals rank is 233
10 Day Gain
Ligand Pharmaceuticals rank is 325
Estimated Revenue Growth
Ligand Pharmaceuticals rank is 400
Historic EPS Growth
Ligand Pharmaceuticals rank is 448
Target Prices
The average analysts' target price is $135.00 for Ligand Pharmaceuticals using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Ligand Pharmaceuticals is ranked 487.
Historic Revenue Growth
Ligand Pharmaceuticals rank is 580
Debt-to-Equity
Ligand Pharmaceuticals rank is 777
SSValue
The StockSelector Value for Ligand Pharmaceuticals is $117.01. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, Ligand Pharmaceuticals is ranked 1274.
Up EPS Surprise
Ligand Pharmaceuticals beat the consensus earnings estimate when it last reported quarterly earnings.
Negative Rankings
Price-to-Sales
Ligand Pharmaceuticals rank is 98
Overbought Stochastics
Ligand Pharmaceuticals rank is 105
High Put/Call
Ligand Pharmaceuticals has a high Put/Call ratio of 3.81 on all open interest of options expiring in the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Ligand Pharmaceuticals is ranked 113.
Negative Guidance
Within the past 90 days Ligand Pharmaceuticals has provided guidance belwo the consensus estimates. Statistics show companies that provide negative guidance underperform the market in the short-term.
Price-to-Book
Ligand Pharmaceuticals rank is 912
90 Day Loss
Ligand Pharmaceuticals rank is 2101
High vPut/Call
Ligand Pharmaceuticals has a high Put/Call ratio of 0.49 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Ligand Pharmaceuticals is ranked 2214.







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2020 StockSelector.com. All rights reserved.